Stephanie Morrissey, RN, OCN

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS4
- INTERVENTIONS2
- SINCE2010

A Drug-Drug Interaction Study of the Effects of XL184 on Rosiglitazone in Subjects With Solid Tumors
April 2010 - December 2011
Carcinoma, Renal Cell
Carcinoma
Thyroid Neoplasms
Adenocarcinoma, Follicular
Rosiglitazone
Xl184



